Root Admin Guide Posted April 24, 2019 Root Admin Report Share Posted April 24, 2019 A study on 54 patients who met eligibility criteria with azelaic acid reports, "The biggest concern was cost (11.1%), with a mean importance score (IS) on a 10-point scale of 9.3." Other than this the report concludes, "Patient-reported side effects were rare. Minor patient-reported side effects and concerns do not appear to affect rosacea-related QoL and medication satisfaction. Compared to a previously conducted study of similar design with patients using metronidazole gel and metronidazole cream, more patients in the current study reported no concerns with their treatment, while the number of patients reporting no side effects, as well as mean SATMED-Q and DLQI scores, were similar." For more information • Now there is a low cost generic Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now